No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
TGTX250117P49000
- 0.00
- 0.000.00%
15min DelayClose Jan 14 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest49.00Strike Price0.00Turnover261.20%IV-64.76%PremiumJan 17, 2025Expiry Date19.26Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9791Delta0.0077Gamma1.54Leverage Ratio-0.0363Theta-0.0024Rho-1.51Eff Leverage0.0013Vega
Intraday
- 5D
- Daily
No Data
News
TG Therapeutics Reports Strong Revenue and Future Goals
TG Therapeutics Shares Climb 7% as Sales Grow for Multiple Sclerosis Drug
B.Riley Financial Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $38
B.Riley Financial Reaffirms Their Buy Rating on TG Therapeutics (TGTX)
What's Going On With TG Therapeutics Stock Tuesday?
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Maintains Target Price $10